Streetbeat News

Products Services

BUD

LLY

NVO

PLNT

PTON

As the New Year begins, investors may consider the impact of resolutions on fitness and health-related stocks. Planet Fitness (PLNT) saw a 0.7% increase, while Anheuser-Busch Inbev (BUD) fell 0.5% on the first trading day of 2024. Historical data shows mixed results for stocks like W.W. International (WW) and Peloton (PTON), with no clear trend correlating New Year resolutions to sustained stock performance. Pharmaceutical companies like Novo Nordisk (NVO) and Eli Lilly (LLY) have seen significant gains due to their weight loss drugs, with shares up 50.7% and 60.7% respectively in 2023.

Portfolio Pulse from Neil Dennis

January 02, 2024 | 5:58 pm

MRNA

PFE

Pfizer, Inc. (NYSE:PFE) shares are trading higher by 4.5% after a 40% loss in 2023. The rise may be in sympathy with Moderna, Inc. (NASDAQ:MRNA), which received an upgrade from Oppenheimer and expects sales growth in 2025. Increased respiratory virus activity could boost demand for Pfizer's vaccines. Pfizer completed the acquisition of Seagen Inc. and provided 2024 revenue guidance below consensus estimates. PFE is trading above its 50-day moving average but below its 52-week high.

Portfolio Pulse from Erica Kollmann

January 02, 2024 | 5:48 pm

EADSF

EADSY

Airbus SE, with its OTC-listed tickers EADSF and EADSY, has reportedly exceeded its target of 720 airplane deliveries for 2023, reaching into the mid-730s. Despite a year-over-year decrease in November deliveries, the company has seen an acceleration in deliveries since the summer. Airbus also made news with its subsidiary's progress on solar-powered drones for communication services. EADSY's stock price saw a slight increase of 0.13% to $38.62 on Tuesday.

Portfolio Pulse from Nabaparna Bhattacharya

January 02, 2024 | 5:43 pm

MRNA

PFE

Pfizer shares are trading higher, potentially due to Moderna's positive sales outlook for 2025 and an increase in respiratory virus activity, which may boost vaccine demand.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 5:35 pm

AVXL

CORT

LBPH

LMDX

RIVN

SNES

VYGR

U.S. stocks traded mixed with the Dow Jones gaining and NASDAQ falling. Energy shares rose while information technology shares fell. Rivian Automotive reported lower-than-expected Q4 vehicle deliveries. Longboard Pharmaceuticals surged on positive study data, while Anavex Life Sciences plunged after an update on its Rett Syndrome program. LumiraDx fell after agreeing to sell its technology platform to Roche, and Corcept Therapeutics dropped due to a court decision favoring Teva Pharmaceuticals. Oil prices decreased, and gold prices saw a slight increase.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 5:15 pm

SNX

Shyft Global Services, a division of TD SYNNEX (NYSE:SNX), has acquired Cokeva, Inc., a leader in IT equipment repair, test, and refurbishment. The acquisition expands Shyft's repair capabilities and global footprint, adding a 220,000 sq. ft. facility in Roseville, California with ISO 9001:2015 and ISO 5/Class 100 certifications. This move adds over 200 repair service experts to Shyft and enhances its service offerings to OEMs in various industries, aligning with Shyft's commitment to sustainability and the circular economy.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 5:06 pm

AAPL

CRM

CVX

DIA

INTC

MSFT

WBA

The Dow Jones Industrial Average (DJIA) saw a significant rise in 2023, with technology stocks leading the gains. Salesforce, Intel, Microsoft, Apple, and Boeing were the top five gainers, while Walgreens, Chevron, Johnson & Johnson, 3M, and Coca-Cola were the biggest losers. The DJIA ETF (DIA) also experienced a strong year. Microsoft's investment in OpenAI and Apple's new iPhone release were notable events. The DJIA's performance, however, lagged behind the S&P 500 and Nasdaq 100, with the 'Magnificent 7' tech stocks driving much of the market's gains.

Portfolio Pulse from Chris Katje

January 02, 2024 | 5:02 pm

Piper Sandler has downgraded BlackLine (NASDAQ:BL) to Underweight with a new price target of $60.00, up from the previous $53.00. Despite the increased target, the downgrade comes as BlackLine shares are trading down 2.79% at $60.70. A move to the target price would mean a 1.15% decline from the current level. BlackLine provides financial accounting close solutions as SaaS, primarily earning revenue in the United States.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 5:00 pm

ATAI

atai Life Sciences shares have risen following the announcement of positive topline results from its Phase 1 study of EMP-01, an orally administered drug.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:55 pm

CHRS

Coherus BioSciences' stock is trading higher following the announcement of the U.S. launch of their product LOQTORZI.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:46 pm